Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Holly Budlong"'
Publikováno v:
Population Health Management. 21:395-400
In 2012, the Fairview Health System implemented a formal care transitions process that included referrals to outpatient services provided by medication therapy management (MTM) pharmacists, among other clinical services. This analysis evaluates the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915ef0f1ddde9111616d5e017ee0a43c
https://doi.org/10.1089/pop.2017.0167
https://doi.org/10.1089/pop.2017.0167
Publikováno v:
Journal of managed carespecialty pharmacy. 23(12)
Biosimilars have the potential to greatly reduce medication costs in the United States. As of July 1, 2017, 5 biosimilars have been approved by the FDA, but only 2 are available for purchase. This commentary outlines the efforts of an integrated heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af89d81e3d26dcc44bbfa70496a005eb
https://pubmed.ncbi.nlm.nih.gov/29172981
https://pubmed.ncbi.nlm.nih.gov/29172981
Autor:
John P. Caloyeras, Holly Budlong, Darcy Malard Johnson, Arpit Rao, Elyssa Mason, Rajesh Belani, Chia-Wei Lin, Joanie Aasen, Erin Conley
Publikováno v:
Journal of Clinical Oncology. 37:e18298-e18298
e18298 Background: Febrile neutropenia (FN) is a key driver of morbidity and mortality in oncology patients receiving myelotoxic chemotherapy. Identification and prophylaxis per guidelines can result in a substantial reduction of FN risk and is a key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04331e91397762114a750aced2437961
https://doi.org/10.1200/jco.2019.37.15_suppl.e18298
https://doi.org/10.1200/jco.2019.37.15_suppl.e18298
Autor:
Jesse Peterson, Holly Budlong
Publikováno v:
Research in Social and Administrative Pharmacy. 13:e22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8571df991549530a222ab1d6f7536a58
https://doi.org/10.1016/j.sapharm.2017.03.026
https://doi.org/10.1016/j.sapharm.2017.03.026
Publikováno v:
Research in Social and Administrative Pharmacy. 13:e24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::633de760905b4da7efe46a13822cb504
https://doi.org/10.1016/j.sapharm.2017.03.032
https://doi.org/10.1016/j.sapharm.2017.03.032